Update on Health Canada’s Regulatory Amendments

From CVMA, Dec 12, 2018:

Veterinary oversight of antimicrobial use is being strengthened in Canada as part of the fight against antimicrobial resistance. This means important changes for you as a practitioner and for the veterinary profession.

Health Canada is moving a number of Medically Important Antimicrobials (MIAs) approved for veterinary use before 2004 to the Prescription Drug List (PDL). With this change, Health Canada will establish the same level of oversight for those MIAs approved before 2004 as for those approved after. As of December 1, 2018, all MIAs for veterinary use will be on the PDL and must be sold by prescription only.

Other regulatory amendments made by Health Canada include:

• Ending Own Use Importation of MIA by animal owners effective November 13, 2017;
• Increased oversight and new rules for the handling of Active Pharmaceutical Ingredients for veterinary use starting May 17, 2018;
• Mandatory reporting of sales information related to MIA; and
• New requirements and the expansion of the veterinary health products program to increase access to alternative animal health products for production animals

Download Timelines: Health Canada is strengthening Canada’s framework for veterinary antimicrobials

To stay up to date on information about these changes, visit here.